Leo Pharma A/S
🏢 View company profile →68Patents
61Active
68Granted
51Portfolio score
Filing activity: Jan 15, 1993 → Dec 1, 2023 · 21 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| USD678783S1 | Applicator for applying preparations to the skin | General | 63 | Active |
| USD709374S1 | Cartridge cap | General | 22 | Active |
| US8034811B2 | Hydroxamic acid esters and pharmaceutical use thereof | Chemistry; Metallurgy | 17 | Active |
| USD725470S1 | Cartridge | General | 14 | Active |
| US6642215B2 | Method of modulating NF-kB activity | Chemistry; Metallurgy | 11 | Expired |
| USRE39706E1 | Crystalline form of a vitamin D analogue | General | 10 | Expired |
| US9273064B2 | Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitors | Chemistry; Metallurgy | 5 | Active |
| US9637499B2 | Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitors | Chemistry; Metallurgy | 5 | Active |
| US8980905B2 | Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitors | Chemistry; Metallurgy | 5 | Active |
| US8338431B2 | Phosphodiesterase inhibitors | Chemistry; Metallurgy | 5 | Active |
| USD718130S1 | Applicator with cap | General | 5 | Active |
| US7253193B2 | Cyanoguanidine prodrugs | Chemistry; Metallurgy | 4 | Expired |
| US9181248B2 | [1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors | Human Necessities | 4 | Active |
| US9908894B2 | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds | Chemistry; Metallurgy | 4 | Active |
| US8940761B2 | [1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors | Human Necessities | 3 | Active |
| US9119781B2 | Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid | Performing Operations; Transporting | 3 | Active |
| US11065257B2 | Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10793580B2 | Substituted pyrazoloazepin-8-ones and their use as phosphodiesterase inhibitors | Human Necessities | 3 | Active |
| US10906915B2 | Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors | Human Necessities | 3 | Active |
| US8952162B2 | Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases | Human Necessities | 3 | Active |
| USD727167S1 | Applicator | General | 2 | Active |
| US7034015B2 | Aminobenzoephenones | Chemistry; Metallurgy | 2 | Expired |
| US9345774B2 | Topical composition comprising a film-forming polymer for delivering an active ingredient to skin | Performing Operations; Transporting | 2 | Active |
| US8455466B2 | Vitamin d analogues, compositions comprising said analogues and their use | Human Necessities | 2 | Active |
| US7807682B2 | Pyridyl cyanoguanidine compounds | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.